Synovus Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30,253
| Closed | -$2.13M | – | 879 |
|
|
2024
Q3 | $2.13M | Buy |
30,253
+6,191
| +26% | +$435K | 0.02% | 366 |
|
|
2024
Q2 | $1.98M | Buy |
24,062
+597
| +3% | +$49.2K | 0.03% | 342 |
|
|
2024
Q1 | $2.05M | Buy |
23,465
+254
| +1% | +$22.2K | 0.03% | 337 |
|
|
2023
Q4 | $2.24M | Buy |
23,211
+65
| +0.3% | +$6.27K | 0.03% | 304 |
|
|
2023
Q3 | $2.05M | Buy |
23,146
+4,973
| +27% | +$440K | 0.02% | 330 |
|
|
2023
Q2 | $1.58M | Sell |
18,173
-784
| -4% | -$68K | 0.02% | 376 |
|
|
2023
Q1 | $1.84M | Sell |
18,957
-1,580
| -8% | -$154K | 0.02% | 349 |
|
|
2022
Q4 | $2.13M | Buy |
20,537
+570
| +3% | +$59K | 0.02% | 328 |
|
|
2022
Q3 | $1.69M | Sell |
19,967
-100
| -0.5% | -$8.47K | 0.02% | 342 |
|
|
2022
Q2 | $1.66M | Buy |
20,067
+485
| +2% | +$40K | 0.02% | 354 |
|
|
2022
Q1 | $1.51M | Sell |
19,582
-1,359
| -6% | -$105K | 0.02% | 376 |
|
|
2021
Q4 | $1.85M | Buy |
20,941
+1,094
| +6% | +$96.5K | 0.02% | 346 |
|
|
2021
Q3 | $1.53M | Buy |
19,847
+1,376
| +7% | +$106K | 0.02% | 354 |
|
|
2021
Q2 | $1.55M | Buy |
18,471
+534
| +3% | +$44.7K | 0.02% | 339 |
|
|
2021
Q1 | $1.35M | Sell |
17,937
-31,308
| -64% | -$2.36M | 0.02% | 320 |
|
|
2020
Q4 | $4.32M | Buy |
49,245
+432
| +0.9% | +$37.9K | 0.05% | 178 |
|
|
2020
Q3 | $3.71M | Buy |
48,813
+12,543
| +35% | +$953K | 0.05% | 180 |
|
|
2020
Q2 | $4.47M | Sell |
36,270
-8,356
| -19% | -$1.03M | 0.06% | 148 |
|
|
2020
Q1 | $3.78M | Buy |
44,626
+6,385
| +17% | +$541K | 0.05% | 184 |
|
|
2019
Q4 | $3.23M | Buy |
38,241
+2,066
| +6% | +$175K | 0.04% | 180 |
|
|
2019
Q3 | $2.44M | Buy |
36,175
+1,023
| +3% | +$69K | 0.04% | 203 |
|
|
2019
Q2 | $3.01M | Buy |
35,152
+3,291
| +10% | +$282K | 0.05% | 176 |
|
|
2019
Q1 | $2.82M | Sell |
31,861
-36
| -0.1% | -$3.19K | 0.05% | 185 |
|
|
2018
Q4 | $2.72M | Sell |
31,897
-168
| -0.5% | -$14.3K | 0.05% | 177 |
|
|
2018
Q3 | $3.11M | Buy |
32,065
+687
| +2% | +$66.7K | 0.05% | 180 |
|
|
2018
Q2 | $2.95M | Sell |
31,378
-873
| -3% | -$82.1K | 0.05% | 179 |
|
|
2018
Q1 | $2.62M | Buy |
32,251
+3,818
| +13% | +$311K | 0.04% | 188 |
|
|
2017
Q4 | $2.54M | Buy |
28,433
+4,918
| +21% | +$439K | 0.04% | 184 |
|
|
2017
Q3 | $2.18M | Buy |
23,515
+2,506
| +12% | +$233K | 0.04% | 185 |
|
|
2017
Q2 | $1.91M | Buy |
21,009
+2,512
| +14% | +$228K | 0.04% | 193 |
|
|
2017
Q1 | $1.62M | Buy |
18,497
+2,240
| +14% | +$196K | 0.03% | 200 |
|
|
2016
Q4 | $1.35M | Buy |
16,257
+3,407
| +27% | +$283K | 0.03% | 212 |
|
|
2016
Q3 | $1.19M | Sell |
12,850
-5,015
| -28% | -$464K | 0.03% | 225 |
|
|
2016
Q2 | $1.39M | Buy |
17,865
+3,493
| +24% | +$271K | 0.03% | 217 |
|
|
2016
Q1 | $1.19M | Buy |
14,372
+2,547
| +22% | +$210K | 0.03% | 237 |
|
|
2015
Q4 | $1.24M | Sell |
11,825
-492
| -4% | -$51.6K | 0.03% | 231 |
|
|
2015
Q3 | $1.3M | Sell |
12,317
-151
| -1% | -$16K | 0.03% | 233 |
|
|
2015
Q2 | $1.71M | Sell |
12,468
-2,549
| -17% | -$349K | 0.04% | 206 |
|
|
2015
Q1 | $1.87M | Sell |
15,017
-2,488
| -14% | -$310K | 0.05% | 192 |
|
|
2014
Q4 | $1.58M | Sell |
17,505
-900
| -5% | -$81.4K | 0.04% | 207 |
|
|
2014
Q3 | $1.33M | Buy |
18,405
+18,283
| +14,986% | +$1.32M | 0.04% | 222 |
|
|
2014
Q2 | $8K | Hold |
122
| – | – | ﹤0.01% | 823 |
|
|
2014
Q1 | $8K | Buy |
+122
| New | +$8K | ﹤0.01% | 833 |
|